The Smart Approach to Preclinical Development for Bacterially Expressed Biologics
May 5, 2022
Tags:
Vectron Biosolutions CEO Trond Erik Vee Aune discusses some of the primary challenges face in the manufacturing of biotherapeutics and explains how Vectron's E. coli technology can help developers overcome many of them.
Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.
.svg)
